AESEG - Medicamentos genéricos

Business Degree, MBA from ESADE and Master in Foreign Trade from the Community of European Management Schools (CEMS) of St. Gallen (Switzerland). Since 2003, he is the Managing Director of KERN Pharma laboratories. His professional career has been developed in the family companies of the chemical-pharmaceutical industries of the group, having responsibility posts in Industrial KERN Española Indukern in Asia, Indukern Chemie AG (Switzerland), Indukern Hong Kong and is currently CEO of KERN Pharma Spain. He is President of AESEG since February of 2008.

Doctorate in Pharmacology by Barcelona University and Programme of General Managing by IESE. She is General Manager of STADA in Spain since 1997 and Manager of Portugal since 2005. Her professional career began in 1975 as a researcher in the Pharmacy Faculty of Barcelona University. Since 1979 she has occupied several managerial positions with responsibilities in the technical management and the management of production plants in the pharmaceutical industry. From 1988 to 1998, she has actively participated in the Spanish Pharmacists of the Industry Association (AEFI), as a member of the board of directors. In 1997, she became part of Bayvit, generic medicines laboratory, as General Manager. She is member of the board of directors of AESEG since 2004.

Pharmacy Degree by the Madrid Complutense University, diploma in Business Administration by CECO, Master in Marketing by the Madrid Autonomic University and Master in Stocks and Financial Markets by the Autonomic University and the ESCA. He has developed his professional career in the pharmaceutical industry with several responsibility posts in Alter Laboratories, Ratiopharm España, Kern Pharma, and has been General Manager of Uso Racional S.L. and PLIVA Group. Since 2008 he is General Manager of Apotex in Spain.

Pharmacy degree by the Barcelona University, MBA by ESADE and PDG by IESE. His professional career has taken place in the pharmaceutical industry, developing several responsibility posts in Prodesfarma, Roche Diagnostics, Vita Group and Procter&Gamble Pharma. Currently he is a member of the management committee of Invent Farma/Lesvi, a group of vertically integrated companies, from the synthesis and production of active substances, to the development, manufacture and commercialisation of generic medicines. Since the end of 2006, he is general manager of Qualigen, the commercial company of Invent Group.

Pharmacy degree from the Madrid Complutense University. Since 1980, he has developed several responsibility roles in Normon Laboratories in departments such as I+D, Quality Control, Planning and Purchases and General Management. Currently he is General Manager and President of Normon Portugal.

Since 1978, he has developed his profesional career in Alter Laboratories, assuming different responsibility posts like Technical Manager and General Manager of Alter España, General Manager of Alter Portugal y General Manager of Alodial Portugal. Since 2001, he is CEO of Alter Genéricos. He is part of the board of directors of AESEG since 2004.

Pharmacy Degree by the Madrid Complutense University and Pharmacist Specialist in Galenic and Industrial Pharmacy. He accumulates more than 15 years experience in the pharmaceutical market with different responsibility positions in Manufacturing and Quality departments. Since 2009 he is Operations Manager for Cinfa Laboratories, where he has also worked as Pharmaceutical Technical director since 2001.

He studied Medicine in the Central University of Barcelona, obtained a Master in Integral Marketing Management at ESADE and is PDD by IESE. He began his career in the pharmaceutical industry in 1986 in Antibióticos Farma S.A., developing commercial and team training tasks. In 1991 he entered Merck to lead a commercial team till 1997, when he became in charge of the creation and development of the generic medicines division of the company, as Commercial Manager at the beginning and as General Manager of Merck Genéricos S.L. since 2002. Currently he is General Manager of the the new Mylan Pharmaceuticals S.L., where he is also Vicepresident and CEO, after the acquisition of the generic medicines subsidiary of Merck by the Northamerican Mylan.

Chemical Engineer by the I.Q.S. and PDD by IESE. He began his career in the pharmaceutical industry in 2002 as Commercial Manager of Sandoz S.A. (Novartis Group). Previously he had developed different business responsibility tasks in the German chemical multinational BASF. Since December 2007 he is General Manager of Ranbaxy in Spain and is part of the board of directors of AESEG since February 2010.

Degree in Veterinary, Master in Biotechnology by the Madrid Complutense University and Executive MBA by the Instituto de Empresa. Since June 2008, he is CEO for Teva Iberia. Previously he had developed his career as General Manager of Bentley Group in Spain, since 1997 till 2008. He worked for Laboratorios Llorente-Juventus as General Manager between 1993 and 1997. From 1990 to 1996, he worked as general manager of the Industrial Microbiology Institute.